Please join the conversation with Dr. Christopher Kabrhel as he discusses the development of the new point of care tools that will help identify patients diagnosed with Low-Risk PE & Low-Risk DVT.
Listen as we engage in a discussion about evidence-based recommendations to guide the identification and outpatient treatment of these patient populations. Support for this episode was provided through an unrestricted grant from Janssen Pharmaceuticals.
